_id

690daf3eccc777a4e85d0aee

Ticker

ANVS

Name

Annovis Bio Inc

Exchange

NYSE

Address

101 Lindenwood Drive, Malvern, PA, United States, 19355

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.annovisbio.com

Description

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer's disease, as well as in phase 3 to treat parkinson's disease; and is in phase 2 clinical trial to treat lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial to treat later stages of alzheimer's disease and dementia. The company was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.

Last Close

4.13

Volume

2925555

Current Price

3.78

Change

-8.474576271186443

Last Updated

2025-11-28T12:15:50.121Z

Image

data:image/webp;base64,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

Ipo Date

2010-02-12T00:00:00.000Z

Market Cap

59802592

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.994

Sentiment Sources

2

Rating

4.25

Target Price

13.75

Strong Buy

2

Buy

1

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

7434975

Operating Income

-7434975

Interest Expense

-

Pretax Income

-7262658

Net Income

-7262658

Eps

-0.3689424335832977

Dividends Per Share

-

Shares Outstanding

26114670

Income Tax Expense

-

EBITDA

-7262658

Operating Margin

-

Total Other Income Expense Net

172317

Cash

15286399

Short Term Investments

-

Receivables

-

Inventories

-

Total Current Assets

17188961

Property Plant Equipment

-

Total Assets

17188961

Payables

2112026

Short Term Debt

-

Long Term Debt

-

Total Liabilities

4032797

Equity

13156164

Depreciation

-

Change In Working Capital

3350396

Cash From Operations

-3487615

Capital Expenditures

5

Cash From Investing

-

Cash From Financing

1643728

Net Change In Cash

-1843887

PE

-

PB

5.655871147547264

ROE

-55.203462042583226

ROA

-42.251873164410576

FCF

-3487620

Fcf Percent

-

Piotroski FScore

1

Health Score

38

Deep Value Investing Score

3.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2

Net Net Investing Score

3

Quality Investing Score

2.5

Value Investing Score

4.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

7434975

Quarters > 0 > income Statement > operating Income

-7434975

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-7262658

Quarters > 0 > income Statement > net Income

-7262658

Quarters > 0 > income Statement > eps

-0.3689424335832977

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

19685071

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-7262658

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

172317

Quarters > 0 > balance Sheet > cash

15286399

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

17188961

Quarters > 0 > balance Sheet > property Plant Equipment

-

Quarters > 0 > balance Sheet > total Assets

17188961

Quarters > 0 > balance Sheet > payables

2112026

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

4032797

Quarters > 0 > balance Sheet > equity

13156164

Quarters > 0 > cash Flow > net Income

-7262658

Quarters > 0 > cash Flow > depreciation

-

Quarters > 0 > cash Flow > change In Working Capital

3350396

Quarters > 0 > cash Flow > cash From Operations

-3487615

Quarters > 0 > cash Flow > capital Expenditures

5

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

1643728

Quarters > 0 > cash Flow > net Change In Cash

-1843887

Quarters > 0 > ratios > PE

-0.3689424335832977

Quarters > 0 > ratios > PB

5.655871147547264

Quarters > 0 > ratios > ROE

-55.203462042583226

Quarters > 0 > ratios > ROA

-42.251873164410576

Quarters > 0 > ratios > FCF

-3487620

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

38

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

6271453

Quarters > 1 > income Statement > operating Income

-6271453

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-6220058

Quarters > 1 > income Statement > net Income

-6220058

Quarters > 1 > income Statement > eps

-0.3192027231946496

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

19486231

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-6271450

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

51395

Quarters > 1 > balance Sheet > cash

17130286

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

21454571

Quarters > 1 > balance Sheet > property Plant Equipment

-

Quarters > 1 > balance Sheet > total Assets

21454571

Quarters > 1 > balance Sheet > payables

974311

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

3124124

Quarters > 1 > balance Sheet > equity

18330447

Quarters > 1 > cash Flow > net Income

-6220058

Quarters > 1 > cash Flow > depreciation

3

Quarters > 1 > cash Flow > change In Working Capital

477551

Quarters > 1 > cash Flow > cash From Operations

-5105889

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

0

Quarters > 1 > cash Flow > net Change In Cash

-5105889

Quarters > 1 > ratios > PE

-0.3192027231946496

Quarters > 1 > ratios > PB

4.01833916979766

Quarters > 1 > ratios > ROE

-33.93293136823123

Quarters > 1 > ratios > ROA

-28.99176124286055

Quarters > 1 > ratios > FCF

-5105889

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

38

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

6282681

Quarters > 2 > income Statement > operating Income

-6282681

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-5537069

Quarters > 2 > income Statement > net Income

-5537069

Quarters > 2 > income Statement > eps

-0.45255978749489173

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

12235000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-6282680

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

745612

Quarters > 2 > balance Sheet > cash

22236175

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

26737253

Quarters > 2 > balance Sheet > property Plant Equipment

-

Quarters > 2 > balance Sheet > total Assets

26737253

Quarters > 2 > balance Sheet > payables

1370189

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

2683366

Quarters > 2 > balance Sheet > equity

24053887

Quarters > 2 > cash Flow > net Income

-5537069

Quarters > 2 > cash Flow > depreciation

1

Quarters > 2 > cash Flow > change In Working Capital

-2503982

Quarters > 2 > cash Flow > cash From Operations

-8099164

Quarters > 2 > cash Flow > capital Expenditures

4

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

19783423

Quarters > 2 > cash Flow > net Change In Cash

11684259

Quarters > 2 > ratios > PE

-0.45255978749489173

Quarters > 2 > ratios > PB

1.922695487843607

Quarters > 2 > ratios > ROE

-23.019435486663756

Quarters > 2 > ratios > ROA

-20.70919177822793

Quarters > 2 > ratios > FCF

-8099168

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

42

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

6734872

Quarters > 3 > income Statement > operating Income

-6734872

Quarters > 3 > income Statement > interest Expense

16939

Quarters > 3 > income Statement > pretax Income

-5864659

Quarters > 3 > income Statement > net Income

-5864659

Quarters > 3 > income Statement > eps

-0.425129322218195

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

13795000

Quarters > 3 > income Statement > income Tax Expense

-5

Quarters > 3 > income Statement > EBITDA

-6734870

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

870213

Quarters > 3 > balance Sheet > cash

10551916

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

13925633

Quarters > 3 > balance Sheet > property Plant Equipment

-

Quarters > 3 > balance Sheet > total Assets

13925633

Quarters > 3 > balance Sheet > payables

2305974

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

4617987

Quarters > 3 > balance Sheet > equity

9307646

Quarters > 3 > cash Flow > net Income

-5864659

Quarters > 3 > cash Flow > depreciation

2

Quarters > 3 > cash Flow > change In Working Capital

-3159159

Quarters > 3 > cash Flow > cash From Operations

-8285346

Quarters > 3 > cash Flow > capital Expenditures

4

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

6200632

Quarters > 3 > cash Flow > net Change In Cash

-2084714

Quarters > 3 > ratios > PE

-0.425129322218195

Quarters > 3 > ratios > PB

5.602393988770093

Quarters > 3 > ratios > ROE

-63.00904654087618

Quarters > 3 > ratios > ROA

-42.11412867192465

Quarters > 3 > ratios > FCF

-8285350

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

37

Valuation > metrics > PE

-0.3689424335832977

Valuation > metrics > PB

5.655871147547264

Valuation > final Score

23.441288524527366

Valuation > verdict

88.5% Overvalued

Profitability > metrics > ROE

-55.203462042583226

Profitability > metrics > ROA

-42.251873164410576

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.30653289211049667

Risk > final Score

80

Risk > verdict

Low

Liquidity > metrics > Current Ratio

8.13861240344579

Liquidity > metrics > Quick Ratio

8.13861240344579

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

39.816608302023404

Prev Valuations > 1

80

Prev Valuations > 2

23.976060112299074

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

-428

Prev Risks > 1

26

Prev Risks > 2

-1530

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-16T22:24:38.515Z